Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

December 12, 2018

Schrödinger, TB Alliance collaborate to advance tuberculosis drug discovery

Schrödinger and TB Alliance have entered into a three-year research collaboration to enhance the development of next-generation tuberculosis (TB) treatments by leveraging Schrödinger’s advanced computational platform for drug discovery.

Schrödinger, TB Alliance collaborate to advance tuberculosis drug discovery